These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25853581)

  • 1. Spiriva Respimat--an oral inhalation spray for COPD.
    Med Lett Drugs Ther; 2015 Mar; 57(1465):49-50. PubMed ID: 25853581
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of tiotropium on heart rate variability in stable chronic obstructive pulmonary disease patients.
    Wu YK; Huang CY; Yang MC; Huang GL; Chen SY; Lan CC
    J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):100-5. PubMed ID: 24840562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tiotropium/olodaterol (Stiolto Respimat) for COPD.
    Med Lett Drugs Ther; 2015 Nov; 57(1482):161-2. PubMed ID: 26583607
    [No Abstract]   [Full Text] [Related]  

  • 4. Tiotropium Respimat Is Effective for the Treatment of Asthma at a Dose Lower Than That for Chronic Obstructive Pulmonary Disease.
    Chin SJ; Durmowicz AG; Chowdhury BA
    Ann Am Thorac Soc; 2016 Feb; 13(2):173-9. PubMed ID: 26650145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, tolerability, and plasma exposure of tiotropium Respimat® in children and adults with cystic fibrosis.
    Konstan MW; Sharma A; Moroni-Zentgraf P; Wang F; Koker P
    J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):137-44. PubMed ID: 25380193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tiotropium Respimat(®) vs. HandiHaler(®): real-life usage and TIOSPIR trial generalizability.
    Schmiedl S; Fischer R; Ibanez L; Fortuny J; Thürmann P; Ballarin E; Ferrer P; Sabaté M; Rottenkolber D; Gerlach R; Tauscher M; Reynolds R; Hasford J; Rottenkolber M
    Br J Clin Pharmacol; 2016 Feb; 81(2):379-88. PubMed ID: 26506314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New Development in inhalation therapy for COPD].
    Teramoto S; Yamamoto H; Yamaguchi Y
    Nihon Naika Gakkai Zasshi; 2005 Apr; 94(4):788-93. PubMed ID: 15865012
    [No Abstract]   [Full Text] [Related]  

  • 8. Tiotropium Respimat in cystic fibrosis: Phase 3 and Pooled phase 2/3 randomized trials.
    Ratjen F; Koker P; Geller DE; Langellier-Cocteaux B; Le Maulf F; Kattenbeck S; Moroni-Zentgraf P; Elborn JS;
    J Cyst Fibros; 2015 Sep; 14(5):608-14. PubMed ID: 25819269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olodaterol + tiotropium bromide for the treatment of chronic obstructive pulmonary disease.
    Cazzola M; Rogliani P; Ora J; Matera MG
    Expert Rev Clin Pharmacol; 2015; 8(5):529-39. PubMed ID: 26294073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the efficacy and safety of tiotropium bromide (5 µg) inhaled via Respimat in Chinese patients with chronic obstructive pulmonary disease.
    Tang Y; Massey D; Zhong NS
    Chin Med J (Engl); 2013; 126(19):3603-7. PubMed ID: 24112149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental Study of Spiriva Respimat Soft Mist Inhaler Spray Characterization: Size Distributions and Velocity.
    Alatrash A; Mehri R; Ogrodnik N; Matida E; Fiorenza F
    J Aerosol Med Pulm Drug Deliv; 2019 Oct; 32(5):293-302. PubMed ID: 31259646
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of inhaled anticholinergic agents in obstructive airway disease.
    Restrepo RD
    Respir Care; 2007 Jul; 52(7):833-51. PubMed ID: 17594728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a role for inhaled anticholinergic therapy in asthma management?
    Parkey SM; Mospan CM
    JAAPA; 2017 Sep; 30(9):9-10. PubMed ID: 28858010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic obstructive pulmonary disease.
    Kerstjens H; Postma D
    Clin Evid; 2002 Jun; (7):1344-57. PubMed ID: 12243121
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tiotropium bromide in the treatment of chronic obstructive lung disease].
    Shmelev EI
    Ter Arkh; 2003; 75(12):69-72. PubMed ID: 14959476
    [No Abstract]   [Full Text] [Related]  

  • 16. Spiriva (Respimat) increases mortality by 52% in patients with COPD: time to take action.
    Ram FS
    N Z Med J; 2011 Jun; 124(1337):117-8. PubMed ID: 21946887
    [No Abstract]   [Full Text] [Related]  

  • 17. Particle size and gastrointestinal absorption influence tiotropium pharmacokinetics: a pilot bioequivalence study of PUR0200 and Spiriva HandiHaler.
    Perry J; Trautman B; Takher-Smith J; Kramer S; Kane K; Silverman M; Tan L; Haughie S; Richter W; Kirkov V; Arsova S; Ward J; Hava DL
    Br J Clin Pharmacol; 2019 Mar; 85(3):580-589. PubMed ID: 30521129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aclidinium bromide oral inhalation powder approved for COPD.
    Traynor K
    Am J Health Syst Pharm; 2012 Sep; 69(17):1446. PubMed ID: 22899732
    [No Abstract]   [Full Text] [Related]  

  • 19. Number needed to treat: enigmatic results for exacerbations in COPD.
    Suissa S
    Eur Respir J; 2015 Apr; 45(4):875-8. PubMed ID: 25829430
    [No Abstract]   [Full Text] [Related]  

  • 20. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD.
    Casaburi R; Kukafka D; Cooper CB; Witek TJ; Kesten S
    Chest; 2005 Mar; 127(3):809-17. PubMed ID: 15764761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.